NTRK1 and neoplasm: Genetic alterations, in particular, in the receptor tyrosine kinase-RAS-BRAF signaling axis lead to constitutive MAPK pathway activation, and these, in turn, influence tumor differentiation, invasiveness, and microenvironmental alterations [33,34].